Sol Gel Technologies Ltd (SLGL) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $89.15
• Market Cap: $99.10M
• EPS: $-1.22
• 52-Week High: $91.14
• 52-Week Low: $4.02

Market Sentiment

Sol Gel Technologies Ltd currently has a Bullish sentiment score of 0.48.

About Sol Gel Technologies Ltd

Sol-Gel Technologies Ltd. is a pioneering clinical-stage pharmaceutical company specializing in the development and commercialization of innovative topical dermatological products. Utilizing its proprietary microencapsulation delivery system, patented in Israel, Sol-Gel aims to enhance the efficacy and safety of treatments for various skin conditions. Headquartered in Ness Ziona, Israel, the company is committed to addressing significant unmet medical needs in dermatology, positioning itself ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Sol Gel Technologies Ltd and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does SLGL pay dividends?

Sol Gel Technologies Ltd (SLGL) does not currently pay a regular dividend.

What is SLGL's market cap?

Sol Gel Technologies Ltd (SLGL) has a market capitalization of $99.10M with a current stock price of $89.15.